Immune system via pattern-recognition receptors and antigen presentation

The immune system's pattern-recognition receptors (PRRs) and antigen presentation machinery constitute a fundamental bridge between innate and adaptive immunity (Janeway & Medzhitov, 2002). PRRs, including Toll-like receptors (TLRs) and NOD-like receptors (NLRs), detect conserved microbial motifs known as pathogen-associated molecular patterns (PAMPs) to initiate immediate defense responses (Kumar et al., 2011). Simultaneously, professional antigen-presenting cells (APCs) internalize pathogens, processing them into peptides for display on Major Histocompatibility Complex (MHC) molecules (Roche & Furuta, 2015). This presentation is crucial for the activation of T-lymphocytes, which orchestrate specific long-term immunity. Dysregulation of these pathways is central to the pathogenesis of autoimmune diseases, chronic inflammation, and the evasion of immune surveillance by tumors (Mogensen, 2009). Pharmacological intervention often targets PRRs using agonists like Imiquimod or adjuvants like Monophosphoryl lipid A to boost vaccine efficacy or anti-tumor activity (Kanzler et al., 2007). Additionally, certain drugs can inadvertently interfere with antigen presentation, leading to severe hypersensitivity reactions, as seen with Abacavir and specific HLA alleles (Illing et al., 2012).

Other names

Innate immune sensing and antigen presentationPRR-mediated immune activationAntigen processing and presentation pathwayInnate-adaptive immune interface

Activation of pattern-recognition receptors (PRRs) to induce cytokine production and enhance Major Histocompatibility Complex (MHC) mediated antigen display to T-cells (Janeway & Medzhitov, 2002; Roche & Furuta, 2015).